Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 923.45
+35.30 (3.97%)
At close: Feb 9, 2026
Zydus Lifesciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 45,255 | 38,595 | 19,603 | 44,873 | 21,336 |
Depreciation & Amortization | 8,868 | 7,345 | 6,965 | 7,086 | 6,934 |
Other Amortization | 290 | 296 | 262 | 275 | 314 |
Loss (Gain) From Sale of Assets | -345 | -169 | -208 | -1,110 | 36 |
Asset Writedown & Restructuring Costs | 2,196 | 177 | 6,042 | - | 731 |
Loss (Gain) From Sale of Investments | -650 | -409 | -483 | -751 | -89 |
Provision & Write-off of Bad Debts | 299 | 206 | 17 | 41 | 114 |
Other Operating Activities | -3,461 | -5,343 | -2,882 | -25,229 | 2,796 |
Change in Accounts Receivable | 12,558 | -7,472 | -8,485 | -1,817 | 4,313 |
Change in Inventory | -4,449 | -20 | 4,407 | -5,255 | -4,797 |
Change in Accounts Payable | 986 | -476 | -1,708 | -1,203 | 1,709 |
Change in Other Net Operating Assets | 6,220 | -1,059 | 3,428 | 4,915 | 686 |
Operating Cash Flow | 67,767 | 31,963 | 26,888 | 21,045 | 32,939 |
Operating Cash Flow Growth | 112.02% | 18.88% | 27.76% | -36.11% | 12.36% |
Capital Expenditures | -17,126 | -9,066 | -10,309 | -12,026 | -8,540 |
Sale of Property, Plant & Equipment | 514 | 237 | 394 | 354 | 70 |
Cash Acquisitions | -3,690 | -7,201 | - | - | - |
Divestitures | - | - | 400 | - | 1,035 |
Sale (Purchase) of Intangibles | - | - | - | 1,127 | - |
Investment in Securities | -64,490 | -18 | 24,113 | -28,633 | -299 |
Other Investing Activities | 1,825 | 1,287 | 776 | 29,175 | 488 |
Investing Cash Flow | -83,723 | -14,752 | 15,350 | -10,003 | -7,246 |
Short-Term Debt Issued | 24,020 | - | - | 2,907 | - |
Long-Term Debt Issued | 42 | 14 | 1,585 | 7,464 | - |
Total Debt Issued | 24,062 | 14 | 1,585 | 10,371 | - |
Short-Term Debt Repaid | - | -3,102 | -23,064 | - | -6,424 |
Long-Term Debt Repaid | - | -827 | -9,960 | -14,221 | -25,744 |
Total Debt Repaid | - | -3,929 | -33,024 | -14,221 | -32,168 |
Net Debt Issued (Repaid) | 24,062 | -3,915 | -31,439 | -3,850 | -32,168 |
Repurchase of Common Stock | - | -7,250 | -8,632 | - | - |
Common Dividends Paid | -3,025 | -6,210 | -2,671 | -3,722 | -15 |
Other Financing Activities | -895 | -413 | -1,262 | -1,111 | 6,706 |
Financing Cash Flow | 20,142 | -17,788 | -44,004 | -8,683 | -25,477 |
Foreign Exchange Rate Adjustments | -214 | -231 | 66 | 86 | -42 |
Miscellaneous Cash Flow Adjustments | 166 | 60 | - | -259 | -1,079 |
Net Cash Flow | 4,138 | -748 | -1,700 | 2,186 | -905 |
Free Cash Flow | 50,641 | 22,897 | 16,579 | 9,019 | 24,399 |
Free Cash Flow Growth | 121.17% | 38.11% | 83.82% | -63.03% | 20.35% |
Free Cash Flow Margin | 21.79% | 11.71% | 9.62% | 5.97% | 16.94% |
Free Cash Flow Per Share | 50.33 | 22.63 | 16.32 | 8.81 | 23.83 |
Cash Interest Paid | 895 | 413 | 1,262 | 1,111 | 1,840 |
Cash Income Tax Paid | 18,019 | 12,858 | 5,920 | 6,746 | 3,450 |
Levered Free Cash Flow | 28,384 | 16,057 | 10,611 | 7,540 | 17,093 |
Unlevered Free Cash Flow | 28,968 | 16,332 | 11,395 | 8,255 | 18,068 |
Change in Working Capital | 15,315 | -9,027 | -2,358 | -3,360 | 1,911 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.